Skip to content

Insider · CIK 0001861246

Kerr Holbrook

officer

Files at AVNS (AVANOS MEDICAL, INC.). First filing Mar 10, 2025, latest Nov 19, 2025.

In brief

Kerr Holbrook files SEC Form 4 as officer at AVNS (AVANOS MEDICAL, INC.). Since Mar 10, 2025, Kerr Holbrook has reported 0 open-market buys worth $0 and 2 open-market sells worth $272k, the latest filed on Nov 19, 2025.

A track record needs three past buys with six months of prices behind them; Kerr Holbrook has 0, so none is measured yet.

The newest scored trade: sold $165k of AVNS on Nov 18, 2025, filed Nov 19, 2025, scored 31 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $165k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $272k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
31Weak
AVNSsell
AVANOS MEDICAL, INC.
$165k
15,000 shares
-15%-
25Weak
AVNSsell
AVANOS MEDICAL, INC.
$107k
7,000 shares
-8%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Nov 18, 2025 AVNS
AVANOS MEDICAL, INC.
15,000
0.03% of outstanding
$165kNov 18, 2025none
Mar 6, 2025 AVNS
AVANOS MEDICAL, INC.
7,000
0.02% of outstanding
$107kMar 6, 2025none

Transactions

Every row this insider has filed, 18 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2025AVNS
AVANOS MEDICAL, INC.
SOpen-market sale
Common Stock
-13,834$11.00$152k85,026Nov 19, 2025
Nov 18, 2025AVNS
AVANOS MEDICAL, INC.
SOpen-market sale
Common Stock
-100$11.01$1,10184,926Nov 19, 2025
Nov 18, 2025AVNS
AVANOS MEDICAL, INC.
SOpen-market sale
Common Stock
-761$11.01$8,37984,165Nov 19, 2025
Nov 18, 2025AVNS
AVANOS MEDICAL, INC.
SOpen-market sale
Common Stock
-305$11.02$3,36183,860Nov 19, 2025
Mar 7, 2025AVNS
AVANOS MEDICAL, INC.
AGrant or award
Common Stock
+22,877$0.00$098,860Mar 11, 2025
Mar 7, 2025AVNS
AVANOS MEDICAL, INC.
AGrant or award
Employee Stock Option (right to buy)derivative
+49,088$0.00$049,088Mar 11, 2025
Mar 6, 2025AVNS
AVANOS MEDICAL, INC.
SOpen-market sale
Common Stock
-7,000$15.25$107k82,047Mar 10, 2025
Mar 6, 2025AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-2,474$15.30$38k79,573Mar 10, 2025
Mar 6, 2025AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-3,590$15.30$55k75,983Mar 10, 2025
Mar 4, 2025AVNS
AVANOS MEDICAL, INC.
MOption exercise
Common Stock
+5,145$0.00$092,393Mar 6, 2025
Mar 4, 2025AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-1,803$15.13$27k90,590Mar 6, 2025
Mar 4, 2025AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-1,543$15.13$23k89,047Mar 6, 2025
Mar 18, 2024AVNS
AVANOS MEDICAL, INC.
MOption exercise
Common Stock
+2,531$0.00$089,727Mar 19, 2024
Mar 18, 2024AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-756$19.09$14k88,971Mar 19, 2024
Mar 18, 2024AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-2,840$19.09$54k86,131Mar 19, 2024
Mar 6, 2024AVNS
AVANOS MEDICAL, INC.
AGrant or award
Common Stock
+36,573$19.14$700k89,814Mar 7, 2024
Mar 6, 2024AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-2,618$19.00$50k87,196Mar 7, 2024
Mar 5, 2024AVNS
AVANOS MEDICAL, INC.
FTax withholding
Common Stock
-1,502$18.76$28k52,310Mar 6, 2024

Questions about Kerr Holbrook

Answered from the filings on this page, as of the latest one.

Is Kerr Holbrook buying or selling?

In the last 12 months Kerr Holbrook reported 0 open-market buys worth $0 and 1 open-market sell worth $165k on SEC Form 4; the latest was sold $165k of AVNS on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.

How did Kerr Holbrook's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kerr Holbrook has 0.

Where does Kerr Holbrook file Form 4?

Kerr Holbrook has filed Form 4 at AVNS (AVANOS MEDICAL, INC.) as SVP, Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kerr Holbrook: insider trades and track record | InsiderTell